<DOC>
	<DOCNO>NCT01865396</DOCNO>
	<brief_summary>The World Health Organization ( WHO ) define palliative care approach improve quality life patient family face life-threatening illness , prevention relief pain physical , psychosocial spiritual problem . The WHO stress palliative care applicable early course illness together therapy intend cure prolong life , chemotherapy radiation therapy . For benefit patient , palliative care however often give ( ) late course disease incurably ill patient . The aim study measure effect interventional palliative care quality life , mood end-of-life care patient advance cancer family . These patient limit life expectancy high symptom burden , lead u suggest patient may benefit palliative care soon diagnosis metastatic disease ( interventional palliative care ) . The research design study randomize control trial , one hand , intervention group patient family receive interventional palliative care combination standard cancer care hand control group patient family receive standard oncologic care . Participants intervention group meet palliative support team shortly diagnosis . Afterwards , palliative support meet least month . This intervention focus topic illness understanding , symptom management , decision make cop disease . Participants control group meet palliative support team patient 's request referral oncologist nursing staff .</brief_summary>
	<brief_title>Effect Early Palliative Care Quality Life Patients With Advanced Cancer : Randomised Controlled Trial .</brief_title>
	<detailed_description />
	<criteria>Patients lifelimiting cancer ( prognosis approximately 1 year ) eligible : Patients within 12 week referral hospital receive first line treatment within 8 12 week new diagnosis ( histological cytological confirm ) : Metastatic advance pancreatic , stomach , oesophageal biliary tract adenocarcinoma ; Metastatic advance NSCLC ( stage IIIB IV ) metastatic SCLC , Malignant pleural mesothelioma Metastatic advance head neck cancer ( stage III IV ) Patients within 12 week progression receive treatment prognosis approximately 1 year : Metastatic locally advance colorectal cancer , progression second line treatment Metastatic advance prostate carcinoma , second line treatment Advanced breast cancer visceral and/or brain metastasis , progression second third line treatment Metastatic melanoma , Metastatic advance kidney cancer , Metastatic advance bladder cancer first line treatment , An Eastern Cooperative Oncology Group ( ECOG ) performance status 0 , 1 2 ability read respond question Dutch . Exclusion criterion : Patients 18 year old Patients impaired cognition Patients meet palliative support team consultation within 6 month inclusion .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>